Citations

Citations to this article as recorded by  

• Cumulative exposure to hypertriglyceridemia and risk of type 2 diabetes in young adults
  Min-Kyung Lee, Kyungdo Han, Bongsung Kim, Jong-Dai Kim, Moon Jung Kim, Byungpyo Kim, Jung Heo, Jiyeon Ahn, Seo-Young Sohn, Jae-Hyuk Lee
  Diabetes Research and Clinical Practice.2024; 208: 111109.     CrossRef
• Usefulness of SPISE Index for Screening and Detection of Early Stages of Insulin Resistance among Chilean Young Adults
  Isabel Pereyra González, Sandra Lopez-Arana
  Annals of Nutrition and Metabolism.2023; 79(4): 372.     CrossRef
• Lipid variability in patients with diabetes mellitus
  Jeongmin Lee, Seung-Hwan Lee
  Cardiovascular Prevention and Pharmacotherapy.2023; 5(4): 126.     CrossRef
• Sesamin: A Promising Therapeutic Agent for Ameliorating Symptoms of Diabetes
  Shu-Ming Huang, Cheng-Hung Chuang, Christine Joyce F. Rejano, Lemmuel L. Tayo, Cheng-Yang Hsieh, Steven Kuan-Hua Huang, Po-Wei Tsai
  Molecules.2023; 28(21): 7255.     CrossRef
• Variability, Mean, and Baseline Values of Metabolic Parameters in Predicting Risk of Type 2 Diabetes
  Duong Duc Pham, Jaekyung Song, Yunwan Jeon, Ibrahimi Hajar, Chae Hun Leem
  The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): 1270.     CrossRef
• Lipid Variability and Diabetes Mellitus
  Jeongmin Lee, Seung-Hwan Lee
  The Journal of Korean Diabetes.2022; 23(1): 28.     CrossRef
• The Risk of Type 2 Diabetes Mellitus in a Russian Population Cohort According to Data from the HAPIEE Project
  Svetlana V. Mustafina, Oksana D. Rymar, Liliya V. Shcherbakova, Evgeniy G. Verevkin, Hynek Pikhart, Olga V. Sazonova, Yuliya I. Ragino, Galina I. Simonova, Martin Bobak, Sofia K. Malyutina, Mikhail I. Voevoda
  Journal of Personalized Medicine.2021; 11(2): 119.     CrossRef
• The influence of VDR polymorphisms on the type 2 diabetes susceptibility in Chinese: an interaction with hypertriglyceridemia
  Dongdong Zhang, Cheng Cheng, Yan Wang, Yuan Xue, Yaping Liu, Yiming Liu, Mingming Feng, Ze Xu, Wenjie Li, Xing Li
  Molecular Genetics and Genomics.2021; 296(4): 837.     CrossRef
• Development and validation of a new diabetes index for the risk classification of present and new-onset diabetes: multicohort study
  Shinje Moon, Ji-Yong Jang, Yumin Kim, Chang-Myung Oh
  Scientific Reports.2021;[Epub]     CrossRef
• Hypertriglyceridemia as an Independent Predictor for Ten-Year Incidence of Diabetes in Thais
  Suranut Charoensri, Supatida Turnsaket, Chatlert Pongchaiyakul
  Vascular Health and Risk Management.2021; Volume 17: 519.     CrossRef
• Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets
  Eun-Jung Rhee
  Endocrinology and Metabolism.2020; 35(1): 85.     CrossRef
• HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study
  Seung-Hwan Lee, Hun-Sung Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Kyungdo Han, Mee Kyoung Kim
  The Journal of Clinical Endocrinology & Metabolism.2019; 104(11): 5633.     CrossRef
• Response: The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study (Endocrinol Metab 2018;33:55–61, Yu Hyun Kwon et al.)
  Eun-Jung Rhee, Yu Hyun Kwon
  Endocrinology and Metabolism.2018; 33(3): 425.     CrossRef
• The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study (Endocrinol Metab 2018;33:55–61, Yu Hyun Kwon et al.)
  Mi Hae Seo
  Endocrinology and Metabolism.2018; 33(2): 305.     CrossRef

The prevalence of hypercholesterolemia in Koreans 30 years old and over was 19.5% in 2015 according to the Korean Nutrition and Health Examination Survey, which means that one-fifth of adults had hypercholesterolemia. The prevalence of hypertriglyceridemia in adults 30 years of age and older was 16.8% in 2015, and men had a 2-fold higher prevalence of hypertriglyceridemia than women (23.9% vs. 10.4%). The awareness of hypercholesterolemia in Koreans was higher in women than among men (62.4% vs. 51.4%). It increased with age; the level of awareness in participants 30 to 49 years of age (32.1% in men and 32.6% in women) was less than half of that observed among respondents ≥65 years old (77.5% in men and 78.0% in women). Regular check-ups for dyslipidemia and the active management thereof are urgent in Korean men aged 30 to 49. In women, the perimenopausal period is crucial for the prevention and management of metabolic syndrome, including dyslipidemia. Overall, improvements in awareness and treatment in the age group of 30 to 49 years in both men and women remain necessary.

Citations

Citations to this article as recorded by  

• Association between weekend catch-up sleep and dyslipidemia among Korean workers
  Ye Seul Jang, Yu Shin Park, Kyungduk Hurh, Eun-Cheol Park, Sung-In Jang
  Scientific Reports.2023;[Epub]     CrossRef
• The association between meat intake and the risk of coronary heart disease in Korean men using the Framingham risk score: A prospective cohort study
  Jiwon Jeong, Kyungjoon Lim, Sangah Shin
  Nutrition, Metabolism and Cardiovascular Diseases.2023; 33(6): 1158.     CrossRef
• New-onset dyslipidemia in adult cancer survivors from medically underserved areas: a 10-year retrospective cohort study
  Yun Hwa Jung, IL Yun, Eun-Cheol Park, Sung-In Jang
  BMC Cancer.2023;[Epub]     CrossRef
• A Paradigm Shift in Dyslipidemia Management in Primary Care: A 12-Month Cohort Study
  Jun Hwa Hong, Ung Jeon, Won-Yong Shin, Weon Kim, Kayeon Seong, Sang-Ho Park, Hee-dong Kim, Joong-Wha Chung, Jaehyuk Choi
  Clinical Therapeutics.2022; 44(5): 698.     CrossRef
• Temporal trends in heart failure over 11 years in the aging Korean population: A retrospective study using the national health insurance database
  Dong-Hyuk Cho, Chan Joo Lee, Jung-Woo Son, Jimi Choi, Jinseub Hwang, Byung-Su Yoo, Yajing Wang
  PLOS ONE.2022; 17(12): e0279541.     CrossRef
• Cardiovascular risk and undertreatment of dyslipidemia in lung cancer survivors: A nationwide population-based study
  In Young Cho, Kyungdo Han, Dong Wook Shin, Sang Hyun Park, Dong Woog Yoon, Sujeong Shin, Su-Min Jeong, Jong Ho Cho
  Current Problems in Cancer.2021; 45(1): 100615.     CrossRef
• Association Between Blood Heavy Metal Concentrations and Dyslipidemia in the Elderly
  Xingmeng Zhu, Yong Fan, Jie Sheng, Ling Gu, Qi Tao, Rui Huang, Kaiyong Liu, Linsheng Yang, Guimei Chen, Hongjuan Cao, Kaichun Li, Fangbiao Tao, Sufang Wang
  Biological Trace Element Research.2021; 199(4): 1280.     CrossRef
• The prevalence of hypercholesterolemia and associated risk factors in Al-Kharj population, Saudi Arabia: a cross-sectional survey
  Jamaan Al-Zahrani, Mamdouh M. Shubair, Sameer Al-Ghamdi, Abdullah A. Alrasheed, Abdulrahman A. Alduraywish, Fayez Saud Alreshidi, Saeed Mastour Alshahrani, Majid Alsalamah, Badr F. Al-Khateeb, Aljawharah Ibraheem Ashathri, Ashraf El-Metwally, Khaled K. Al
  BMC Cardiovascular Disorders.2021;[Epub]     CrossRef
• Prevalence, awareness, treatment, and control of dyslipidemia among diabetes mellitus patients and predictors of optimal dyslipidemia control: results from the Korea National Health and Nutrition Examination Survey
  Seung Jae Kim, Oh. Deog Kwon, Kyung-Soo Kim
  Lipids in Health and Disease.2021;[Epub]     CrossRef
• Case Report of a Patient Diagnosed with Fatty Liver Accompanied by Hypertriglyceridemia
  Soyoung Hur, Soyeon An, Eujin Kim, Cho-Hyun Hwang, Eungyeong Jang, Youngchul Kim, Jang-Hoon Lee
  The Journal of Internal Korean Medicine.2021; 42(2): 207.     CrossRef
• Changes in Cardiovascular Risk Factors in Residents of the Siberian Region (According to Epidemiological Studies)
  G. V. Artamonova, S. A. Maksimov, D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, T. A. Mulerova, E. B. Shapovalova, A. S. Agienko, O. V. Nakhratova, O. L. Barbarash
  Rational Pharmacotherapy in Cardiology.2021; 17(3): 362.     CrossRef
• Pre-existing Depression among Newly Diagnosed Dyslipidemia Patients and Cardiovascular Disease Risk
  Jihoon Andrew Kim, Seulggie Choi, Daein Choi, Sang Min Park
  Diabetes & Metabolism Journal.2020; 44(2): 307.     CrossRef
• Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study
  Ye Seul Yang, Bo Ram Yang, Mi-Sook Kim, Yunji Hwang, Sung Hee Choi
  Lipids in Health and Disease.2020;[Epub]     CrossRef
• Risk factors for cardiovascular disease in ethnic Europeans and Koreans living in the Primorsky Krai
  D. Yu. Bogdanov, V. A. Nevzorova, V. B. Shumatov, E. A. Kondrashova, E. Yu. Shestopalov
  Cardiovascular Therapy and Prevention.2020; 19(1): 40.     CrossRef
• Effect of Smartphone-Based Lifestyle Coaching App on Community-Dwelling Population With Moderate Metabolic Abnormalities: Randomized Controlled Trial
  So Mi Jemma Cho, Jung Hyun Lee, Jee-Seon Shim, Hyungseon Yeom, Su Jin Lee, Yong Woo Jeon, Hyeon Chang Kim
  Journal of Medical Internet Research.2020; 22(10): e17435.     CrossRef
• Risk factors for cardiovascular disease in ethnic Europeans and Koreans living in the Primorsky Krai
  D. Yu. Bogdanov, V. A. Nevzorova, V. B. Shumatov, E. A. Kondrashova, E. Yu. Shestopalov
  Cardiovascular Therapy and Prevention.2020; 19(1): 40.     CrossRef
• The effect of healthy Nordic diet on cardio-metabolic markers: a systematic review and meta-analysis of randomized controlled clinical trials
  Nahid Ramezani-Jolfaie, Mohammad Mohammadi, Amin Salehi-Abargouei
  European Journal of Nutrition.2019; 58(6): 2159.     CrossRef
• Association between Low-Intensity Smoking and Metabolic Syndrome in Korean Men
  Minji Park, Seran Min, Yu Jin Cho, Sunwoo Kim, Hyuktae Kwon, Hee-Kyung Joh, Bumjo Oh, Seung-Won Oh, Ho Chun Choi, Cheol Min Lee
  Journal of the Korean Society for Research on Nicotine and Tobacco.2019; 10(2): 89.     CrossRef
• Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study
  Chang-Wook Nam, Dong-Soo Kim, Jianyong Li, Marie T. Baccara-Dinet, Ivy Li, Ji-Hyun Kim, Chong-Jin Kim
  The Korean Journal of Internal Medicine.2019; 34(6): 1252.     CrossRef
• Progress of Short-term Herbal Medicine Administration for Hypertriglyceridemia: a Case Report
  Bo-min Kim, Hee-geun Jo
  The Journal of Internal Korean Medicine.2019; 40(3): 517.     CrossRef
• Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study
  Nam Hoon Kim, Ki Hoon Han, Jimi Choi, Juneyoung Lee, Sin Gon Kim
  BMJ.2019; : l5125.     CrossRef
• The risk of herpes zoster virus infection in patients with depression
  Hyo Geun Choi, Eui-Joong Kim, Young Kyung Lee, Miyoung Kim
  Medicine.2019; 98(40): e17430.     CrossRef
• Effect of Change in Total Cholesterol Levels on Cardiovascular Disease Among Young Adults
  Su‐Min Jeong, Seulggie Choi, Kyuwoong Kim, Sung Min Kim, Gyeongsil Lee, Seong Yong Park, Yeon‐Yong Kim, Joung Sik Son, Jae‐Moon Yun, Sang Min Park
  Journal of the American Heart Association.2018;[Epub]     CrossRef
• Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
  Woohyeun Kim, Yeonyee E. Yoon, Sung-Hee Shin, Jang-Whan Bae, Bum-Kee Hong, Soon Jun Hong, Ki Chul Sung, Seung Hwan Han, Weon Kim, Moo-Yong Rhee, Sang-Hyun Kim, Sang Eun Lee, Min Su Hyon, Gyo-Seung Hwang, Jang Won Son, Jang-Young Kim, Min Kyu Kim, Sang Woo
  Clinical Therapeutics.2018; 40(6): 993.     CrossRef
• Prevalence of dyslipidemia among the population of a large region of Eastern Siberia and its association with sociodemographic and behavioral factors
  Yu. I. Grinshtein, V. V. Shabalin, R. R. Ruf, M. M. Petrova, S. A. Shal'nova
  Profilakticheskaya meditsina.2018; 21(5): 63.     CrossRef

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance, obesity, and dyslipidemia. NAFLD encompasses a wide range of states from the simple accumulation of triglycerides in the hepatocytes to serious states accompanied by inflammation and fibrosis in the liver. De novo lipogenesis has been shown to be a significant factor in the development of hepatic steatosis in insulin-resistant states. Sterol regulatory element binding protein-1c (SREBP-1c) is the main transcription factor that mediates the activation of lipogenesis, and SREBP cleavage activating protein (SCAP) is required for the activation of SREBPs. Here, recent animal studies that suggest SCAP as a therapeutic target for hepatic steatosis and hypertriglyceridemia are discussed.

Citations

Citations to this article as recorded by  

• SREBPs as the potential target for solving the polypharmacy dilemma
  Xue Wang, Yanqiu Chen, Heyu Meng, Fanbo Meng
  Frontiers in Physiology.2024;[Epub]     CrossRef
• The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis
  Preethi Chandrasekaran, Ralf Weiskirchen
  International Journal of Molecular Sciences.2024; 25(2): 1109.     CrossRef
• Expression and correlation analysis of silent information regulator 1 (SIRT1), sterol regulatory element-binding protein-1 (SREBP1), and pyroptosis factor in gestational diabetes mellitus
  Ning Han, Xin-yuan Chang, Zi-li Yuan, Yi-zhan Wang
  The Journal of Maternal-Fetal & Neonatal Medicine.2024;[Epub]     CrossRef
• Uxi (Endopleura uchi (Huber) Cuatrec) bark extract mitigates HFD-induced adiposity in rats via targeting oxidative stress, and lipogenic genes expression
  Eman A.R. Abdelghffar, Zuhair M. Mohammedsaleh, Raha Osailan, Aisha Elaimi, Wafae Ouchari, Mohamed A.O. Abdelfattah, Mona F. Mahmoud, Mansour Sobeh
  Journal of Functional Foods.2024; 114: 106034.     CrossRef
• Robinetin Alleviates Metabolic Failure in Liver through Suppression of p300–CD38 Axis
  Ji-Hye Song, Hyo-Jin Kim, Jangho Lee, Seung-Pyo Hong, Min-Yu Chung, Yu-Geun Lee, Jae Ho Park, Hyo-Kyoung Choi, Jin-Taek Hwang
  Biomolecules & Therapeutics.2024; 32(2): 214.     CrossRef
• Regeneration of Non-Alcoholic Fatty Liver Cells Using Chimeric FGF21/HGFR: A Novel Therapeutic Approach
  Sung-Jun Kim, So-Jung Kim, Jeongeun Hyun, Hae-Won Kim, Jun-Hyeog Jang
  International Journal of Molecular Sciences.2024; 25(6): 3092.     CrossRef
• Evolutionary analysis of buffalo sterol regulatory element-binding factor (SREBF) family genes and their affection on milk traits
  Tingzhu Ye, Jing Yuan, Sayed Haidar Abbas Raza, Tingxian Deng, Lv Yang, Muhammad Jamil Ahmad, Seyed Mahdi Hosseini, Xinxin Zhang, Muna O Alamoudi, Qwait AlGabbani, Youssef S Alghamdi, Chao Chen, Aixin Liang, Nicola M. Schreurs, Liguo Yang
  Animal Biotechnology.2023; 34(7): 2082.     CrossRef
• Hepatic Pin1 Expression, Particularly in Nuclei, Is Increased in NASH Patients in Accordance with Evidence of the Role of Pin1 in Lipid Accumulation Shown in Hepatoma Cell Lines
  Machi Kanna, Yusuke Nakatsu, Takeshi Yamamotoya, Akifumi Kushiyama, Midori Fujishiro, Hideyuki Sakoda, Hiraku Ono, Koji Arihiro, Tomoichiro Asano
  International Journal of Molecular Sciences.2023; 24(10): 8847.     CrossRef
• Dietary acetate promotes growth and nutrients deposition in Nile tilapia (Oreochromis niloticus) through increasing acetyl-CoA-triggered energy production
  Wen-Hao Zhou, Samwel M. Limbu, Yuan Luo, Rui-Xin Li, Jiong Ren, Fang Qiao, Mei-Ling Zhang, Zhen-Yu Du
  Aquaculture.2023; 575: 739750.     CrossRef
• Palmitate로 유발된 비알코올성 지방간 세포 모델에서 블랙커런트 초임계 추출물의 지방증 개선효과
  수정 이, 은숙 양, 영호 김, 혜연 김, 혜란 최, 석 김, 태호 류
  Korean Journal of Food and Cookery Science.2023; 39(3): 178.     CrossRef
• PM2.5 induced liver lipid metabolic disorders in C57BL/6J mice
  Chenxiao Zhang, Tengfei Ma, Chang Liu, Ding Ma, Jian Wang, Meng Liu, Jinjun Ran, Xueting Wang, Xiaobei Deng
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• High Gamma-Aminobutyric Acid (GABA) Oolong Tea Alleviates High-Fat Diet-Induced Metabolic Disorders in Mice
  Monthana Weerawatanakorn, Sang He, Chun-Han Chang, Yen-Chun Koh, Meei-Ju Yang, Min-Hsiung Pan
  ACS Omega.2023; 8(37): 33997.     CrossRef
• MicroRNA-19a regulates milk fat metabolism by targeting SYT1 in bovine mammary epithelial cells
  Baojun Yu, Jiamin Liu, Zhengyun Cai, Tong Mu, Di Zhang, Xiaofang Feng, Yaling Gu, Juan Zhang
  International Journal of Biological Macromolecules.2023; 253: 127096.     CrossRef
• SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies
  Na Li, Xiaodan Li, Yifu Ding, Xiao Liu, Karin Diggle, Tatiana Kisseleva, David A. Brenner
  Biomedicines.2023; 11(12): 3280.     CrossRef
• Daidzein stimulates fatty acid-induced fat deposition in C2C12 myoblast cells via the G protein-coupled receptor 30 pathway
  Chengjian Zhou, Ping Li, Meihong Han, Xuejun Gao
  Animal Biotechnology.2022; 33(5): 851.     CrossRef
• Hepatocyte steatosis inhibits hepatitis B virus secretion via induction of endoplasmic reticulum stress
  Qichuang Liu, Maoyuan Mu, Huan Chen, Guoyuan Zhang, Yanqing Yang, Jun Chu, Ying Li, Fangwan Yang, Shide Lin
  Molecular and Cellular Biochemistry.2022; 477(11): 2481.     CrossRef
• The cholesterol pathway: impact on immunity and cancer
  Ryan J. King, Pankaj K. Singh, Kamiya Mehla
  Trends in Immunology.2022; 43(1): 78.     CrossRef
• Hepatic retinaldehyde dehydrogenases are modulated by tocopherol supplementation in mice with hepatic steatosis
  Amanda D'Espessailles, Valeria Campos, Nevenka Juretić, Gladys S. Tapia, Paulina Pettinelli
  Nutrition.2022; 94: 111539.     CrossRef
• CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing
  Han Zeng, Hong Qin, Meng Liao, Enze Zheng, Xiaoqing Luo, Anhua Xiao, Yiyu Li, Lin Chen, Li Wei, Lei Zhao, Xiong Z. Ruan, Ping Yang, Yaxi Chen
  Molecular Metabolism.2022; 57: 101428.     CrossRef
• Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions
  Claudio M. Fader Kaiser, Patricia S. Romano, M. Cristina Vanrell, Cristian A. Pocognoni, Julieta Jacob, Benjamín Caruso, Laura R. Delgui
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, pl
  Neeta B Amin, Amanda Darekar, Quentin M Anstee, Vincent Wai-Sun Wong, Frank Tacke, Manoli Vourvahis, Douglas S Lee, Michael Charlton, Naim Alkhouri, Atsushi Nakajima, Carla Yunis
  BMJ Open.2022; 12(3): e056159.     CrossRef
• Identification of microRNA Transcriptome Involved in Bovine Intramuscular Fat Deposition
  Susan K. Duckett, Maslyn A. Greene
  Frontiers in Veterinary Science.2022;[Epub]     CrossRef
• Camellia (Camellia oleifera bel.) seed oil reprograms gut microbiota and alleviates lipid accumulation in high fat-fed mice through the mTOR pathway
  Jing Gao, Li Ma, Jie Yin, Gang Liu, Jie Ma, SiTing Xia, SaiMing Gong, Qi Han, TieJun Li, YongZhong Chen, YuLong Yin
  Food & Function.2022; 13(9): 4977.     CrossRef
• The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
  Yuxian Yang, Shuting Li, Yuechao Xu, Jing Ke, Dong Zhao
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1505.     CrossRef
• Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation
  Yuanli Wang, Rulong Chen, Jingyi Li, Guodong Zeng, Juntao Yuan, Jingran Su, Chunyan Wu, Zhongbing Lu, Fang Zhang, Wenjun Ding
  Antioxidants.2022; 11(6): 1093.     CrossRef
• Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis
  Satoshi Kawamura, Yuki Matsushita, Shigeyuki Kurosaki, Mizuki Tange, Naoto Fujiwara, Yuki Hayata, Yoku Hayakawa, Nobumi Suzuki, Masahiro Hata, Mayo Tsuboi, Takahiro Kishikawa, Hiroto Kinoshita, Takuma Nakatsuka, Masaya Sato, Yotaro Kudo, Yujin Hoshida, At
  Journal of Clinical Investigation.2022;[Epub]     CrossRef
• Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation
  Pan Li, Ruoyu Zhang, Meng Wang, Yuwei Chen, Zhiwei Chen, Xiumei Ke, Ling Zuo, Jianwei Wang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Identification and validation of immune related core transcription factors GTF2I in NAFLD
  Minbo Zhang, Yu Zhang, Xiaoxiao Jiao, Linying Lai, Yiting Qian, Bo Sun, Wenzhuo Yang
  PeerJ.2022; 10: e13735.     CrossRef
• Lipid-lowering effect of microencapsulated peptides from brewer's spent grain in high-sucrose diet-fed rats
  M.R. Ferreira, A.G. Garzón, M.E. Oliva, R.E. Cian, S.R. Drago, M.E. D'Alessandro
  Food Bioscience.2022; 49: 101981.     CrossRef
• The SREBP-dependent regulation of cyclin D1 coordinates cell proliferation and lipid synthesis
  Arwa Aldaalis, Maria T. Bengoechea-Alonso, Johan Ericsson
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Targets of statins intervention in LDL-C metabolism: Gut microbiota
  ChangXin Sun, ZePing Wang, LanQing Hu, XiaoNan Zhang, JiYe Chen, ZongLiang Yu, LongTao Liu, Min Wu
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Regulation of lipid droplet (LD) formation in hepatocytes via regulation of SREBP1c by non-coding RNAs
  Shereen A. El Sobky, Nourhan K. Aboud, Nihal M. El Assaly, Injie O. Fawzy, Nada El-Ekiaby, Ahmed I. Abdelaziz
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Aspalathin-rich green rooibos tea in combination with glyburide and atorvastatin enhances lipid metabolism in a db/db mouse model
  Oelfah Patel, Christo J. F. Muller, Elizabeth Joubert, Bernd Rosenkranz, Johan Louw, Charles Awortwe
  Frontiers in Clinical Diabetes and Healthcare.2022;[Epub]     CrossRef
• Capparis spinosa improves non-alcoholic steatohepatitis through down-regulating SREBP-1c and a PPARα-independent pathway in high-fat diet-fed rats
  Rasoul Akbari, Hamid Yaghooti, Mohammad Taha Jalali, Laya Sadat Khorsandi, Narges Mohammadtaghvaei
  BMC Research Notes.2022;[Epub]     CrossRef
• Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways
  Shuhua Shen, Kungen Wang, Yihui Zhi, Yue Dong
  Pharmaceutical Biology.2022; 60(1): 1949.     CrossRef
• CYP51-mediated cholesterol biosynthesis is required for the proliferation of CD4+ T cells in Sjogren’s syndrome
  Junhao Yin, Jiayao Fu, Yanxiong Shao, Jiabao Xu, Hui Li, Changyu Chen, Yijie Zhao, Zhanglong Zheng, Chuangqi Yu, Lingyan Zheng, Baoli Wang
  Clinical and Experimental Medicine.2022; 23(5): 1691.     CrossRef
• Differential TM4SF5‐mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression
  Jihye Ryu, Eunmi Kim, Min‐Kyung Kang, Dae‐Geun Song, Eun‐Ae Shin, Haesong Lee, Jae Woo Jung, Seo Hee Nam, Ji Eon Kim, Hye‐Jin Kim, Taekwon Son, Semi Kim, Hwi Young Kim, Jung Weon Lee
  The Journal of Pathology.2021; 253(1): 55.     CrossRef
• Changes in Glutathione Content in Liver Diseases: An Update
  Mariapia Vairetti, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Andrea Ferrigno, Clarissa Berardo
  Antioxidants.2021; 10(3): 364.     CrossRef
• Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings
  Baris Akinci, Angela Subauste, Nevin Ajluni, Nazanene H. Esfandiari, Rasimcan Meral, Adam H. Neidert, Akin Eraslan, Rita Hench, Diana Rus, Barbara Mckenna, Hero K. Hussain, Thomas L. Chenevert, Marwan K. Tayeh, Amit R. Rupani, Jeffrey W. Innis, Christos S
  Med.2021; 2(7): 814.     CrossRef
• Prediction of Srebp-1 as a Key Target of Qing Gan San Against MAFLD in Rats via RNA-Sequencing Profile Analysis
  Bendong Yang, Jingyue Sun, Shufei Liang, Peixuan Wu, Rui Lv, Yanping He, Deqi Li, Wenlong Sun, Xinhua Song
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake
  Miaoqing Hu, Fan Yang, Yawen Huang, Xin You, Desheng Liu, Shan Sun, Sen-Fang Sui
  Science Advances.2021;[Epub]     CrossRef
• Identification and Optimization of a Minor Allele-Specific siRNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver Disease
  Justin K. Murray, Jason Long, Lei Liu, Shivani Singh, Danielle Pruitt, Michael Ollmann, Elissa Swearingen, Miki Hardy, Oliver Homann, Bin Wu, Jerry Ryan Holder, Kelvin Sham, Brad Herberich, Mei-Chu Lo, Hui Dou, Artem Shkumatov, Monica Florio, Ingrid C. Ru
  Nucleic Acid Therapeutics.2021; 31(5): 324.     CrossRef
• Molecular mechanism of DLBS3733, a bioactive fraction of Lagerstroemia speciosa (L.) Pers., on ameliorating hepatic lipid accumulation in HepG2 cells
  Olivia M. Tandrasasmita, Guntur Berlian, Raymond R. Tjandrawinata
  Biomedicine & Pharmacotherapy.2021; 141: 111937.     CrossRef
• The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis
  Margaret Vourakis, Gaétan Mayer, Guy Rousseau
  International Journal of Molecular Sciences.2021; 22(15): 8074.     CrossRef
• Inhibition of Atherosclerosis and Liver Steatosis by Agmatine in Western Diet-Fed apoE-Knockout Mice Is Associated with Decrease in Hepatic De Novo Lipogenesis and Reduction in Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio
  Anna Wiśniewska, Aneta Stachowicz, Katarzyna Kuś, Magdalena Ulatowska-Białas, Justyna Totoń-Żurańska, Anna Kiepura, Kamila Stachyra, Maciej Suski, Mariusz Gajda, Jacek Jawień, Rafał Olszanecki
  International Journal of Molecular Sciences.2021; 22(19): 10688.     CrossRef
• Therapeutic Targeting of Nonalcoholic Fatty Liver Disease by Downregulating SREBP-1C Expression via AMPK-KLF10 Axis
  Yu-Chi Chen, Rong-Jane Chen, Szu-Yuan Peng, Winston C. Y. Yu, Vincent Hung-Shu Chang
  Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
• Regulation of Key Genes for Milk Fat Synthesis in Ruminants
  Tong Mu, Honghong Hu, Yanfen Ma, Xiaofang Feng, Juan Zhang, Yaling Gu
  Frontiers in Nutrition.2021;[Epub]     CrossRef
• Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
  Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won-Young Lee
  Endocrinology and Metabolism.2020; 35(1): 165.     CrossRef
• Lipidomic profiling analysis of the phospholipid molecules in SCAP-induced lipid droplet formation in bovine mammary epithelial cells
  Liqiang Han, Kun Pang, Xiu ling Li, Juan J Loor, Guo yu Yang, Tengyun Gao
  Prostaglandins & Other Lipid Mediators.2020; 149: 106420.     CrossRef
• Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research
  Amedeo Lonardo, Ayako Suzuki
  Journal of Clinical Medicine.2020; 9(5): 1278.     CrossRef
• Smurf1 aggravates non‐alcoholic fatty liver disease by stabilizing SREBP‐1c in an E3 activity‐independent manner
  Xin Zhang, Yutao Zhan, Wenjun Lin, Fei Zhao, Chaojing Guo, Yujiao Chen, Mengge Du, Dongnian Li, Lingqiang Zhang, Wei An, Hong‐Rui Wang, Ping Xie
  The FASEB Journal.2020; 34(6): 7631.     CrossRef
• Beneficial Effects of SREBP Decoy Oligodeoxynucleotide in an Animal Model of Hyperlipidemia
  Hyun-Jin An, Jung-Yeon Kim, Mi-Gyeong Gwon, Hyemin Gu, Hyun-Ju Kim, Jaechan Leem, Sung Won Youn, Kwan-Kyu Park
  International Journal of Molecular Sciences.2020; 21(2): 552.     CrossRef
• Lack of Augmenter of Liver Regeneration Disrupts Cholesterol Homeostasis of Liver in Mice by Inhibiting the AMPK Pathway
  Xin Wang, Ling‐yue Dong, Qu‐jing Gai, Wei‐lun Ai, Yuan Wu, Wei‐chun Xiao, Jing Zhang, Wei An
  Hepatology Communications.2020; 4(8): 1149.     CrossRef
• HESA-A Attenuates Hepatic Steatosis in NAFLD Rat Model Through the Suppression of SREBP-1c and NF-kβ
  M. Efati, M. Khorrami, Z. Jangravi, A. Z. Mahmoudabadi, M. Raeiszadeh, J. R. Sarshoori
  International Journal of Peptide Research and Therapeutics.2020; 26(3): 1283.     CrossRef
• Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c
  Kairui Tang, Yuanjun Deng, Chuiyang Zheng, Huan Nie, Maoxing Pan, Runsen Chen, Jiqian Xie, Qinhe Yang, Yupei Zhang
  Oxidative Medicine and Cellular Longevity.2020; 2020: 1.     CrossRef
• (−)-Epicatechin and the comorbidities of obesity
  Eleonora Cremonini, Dario E. Iglesias, Jiye Kang, Giovanni E. Lombardo, Zahra Mostofinejad, Ziwei Wang, Wei Zhu, Patricia I. Oteiza
  Archives of Biochemistry and Biophysics.2020; 690: 108505.     CrossRef
• microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance
  Bernice Monchusi, Mandeep Kaur
  Genes & Cancer.2020; 11(1-2): 20.     CrossRef
• Cellular acidosis triggers human MondoA transcriptional activity by driving mitochondrial ATP production
  Blake R Wilde, Zhizhou Ye, Tian-Yeh Lim, Donald E Ayer
  eLife.2019;[Epub]     CrossRef
• Differential Recovery Speed of Activity and Metabolic Rhythms in Rats After an Experimental Protocol of Shift-Work
  Nadia Saderi, Adrián Báez-Ruiz, Lucia E. Azuara-Álvarez, Carolina Escobar, Roberto C. Salgado-Delgado
  Journal of Biological Rhythms.2019; 34(2): 154.     CrossRef
• Genetically modified mouse models to study hepatic neutral lipid mobilization
  Guenter Haemmerle, Achim Lass
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2019; 1865(5): 879.     CrossRef
• Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism
  Elham Karimi-Sales, Abbas Ebrahimi-Kalan, Mohammad Reza Alipour
  Biomedicine & Pharmacotherapy.2019; 109: 1306.     CrossRef
• A new pathway to eSCAPe lipotoxicity
  Fadila Benhamed, Catherine Postic
  Clinics and Research in Hepatology and Gastroenterology.2018; 42(1): 3.     CrossRef
• Overexpression of SREBF chaperone (SCAP) enhances nuclear SREBP1 translocation to upregulate fatty acid synthase (FASN) gene expression in bovine mammary epithelial cells
  L.Q. Han, T.Y. Gao, G.Y. Yang, J.J. Loor
  Journal of Dairy Science.2018; 101(7): 6523.     CrossRef
• Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
  Gyuri Kim, Suk-Yong Jang, Chung Mo Nam, Eun Seok Kang
  Journal of Hepatology.2018; 68(3): 476.     CrossRef
• Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD)
  Dominika Maciejewska, Wojciech Marlicz, Karina Ryterska, Marcin Banaszczak, Dominika Jamioł-Milc, Ewa Stachowska
  Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
• Systems Analysis of the Liver Transcriptome in Adult Male Zebrafish Exposed to the Plasticizer (2-Ethylhexyl) Phthalate (DEHP)
  Matthew Huff, Willian A. da Silveira, Oliana Carnevali, Ludivine Renaud, Gary Hardiman
  Scientific Reports.2018;[Epub]     CrossRef
• Inactivation of ceramide synthase 2 catalytic activity in mice affects transcription of genes involved in lipid metabolism and cell division
  Andreas Bickert, Paul Kern, Martina van Uelft, Stefanie Herresthal, Thomas Ulas, Katharina Gutbrod, Bernadette Breiden, Joachim Degen, Konrad Sandhoff, Joachim L. Schultze, Peter Dörmann, Dieter Hartmann, Reinhard Bauer, Klaus Willecke
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2018; 1863(7): 734.     CrossRef
• Paradoxical Protective Effect of Perfluorooctanesulfonic Acid Against High-Fat Diet–Induced Hepatic Steatosis in Mice
  Ian Huck, Kevin Beggs, Udayan Apte
  International Journal of Toxicology.2018; 37(5): 383.     CrossRef
• Developmental and extrahepatic physiological functions of SREBP pathway genes in mice
  Luke J. Engelking, Mary Jo Cantoria, Yanchao Xu, Guosheng Liang
  Seminars in Cell & Developmental Biology.2018; 81: 98.     CrossRef
• Herbacetin, a flaxseed flavonoid, ameliorates high percent dietary fat induced insulin resistance and lipid accumulation through the regulation of hepatic lipid metabolizing and lipid-regulating enzymes
  Chinnadurai Veeramani, Mohammed A. Alsaif, Khalid S. Al-Numair
  Chemico-Biological Interactions.2018; 288: 49.     CrossRef
• Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals
  Giuseppe Della Pepa, Claudia Vetrani, Gianluca Lombardi, Lutgarda Bozzetto, Giovanni Annuzzi, Angela Rivellese
  Nutrients.2017; 9(10): 1065.     CrossRef
• MDG-1, a Potential Regulator of PPARα and PPARγ, Ameliorates Dyslipidemia in Mice
  Xu Wang, Linlin Shi, Sun Joyce, Yuan Wang, Yi Feng
  International Journal of Molecular Sciences.2017; 18(9): 1930.     CrossRef

Citations

Citations to this article as recorded by  

• Triglyceridemic Waist Phenotypes as Risk Factors for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  Fiorella E. Zuzunaga-Montoya, Víctor Juan Vera-Ponce
  International Journal of Statistics in Medical Research.2024; 13: 19.     CrossRef
• Association between hypertriglyceridemic-waist phenotype and circadian syndrome risk: a longitudinal cohort study
  Li-Kun Hu, Yu-Hong Liu, Kun Yang, Ning Chen, Lin-Lin Ma, Yu-Xiang Yan
  Hormones.2023; 22(3): 457.     CrossRef
• Caracterización del fenotipo de cintura hipertrigliceridémica en pacientes con diabetes mellitus tipo 2 en España: un estudio epidemiológico
  I. Miñambres, J. Sánchez-Hernández, G. Cuixart, A. Sánchez-Pinto, J. Sarroca, A. Pérez
  Revista Clínica Española.2021; 221(10): 576.     CrossRef
• Association of “hypertriglyceridemic waist” with increased 5-year risk of subclinical atherosclerosis in a multi-ethnic population: a prospective cohort study
  Peyman Namdarimoghaddam, Adeleke Fowokan, Karin H. Humphries, G. B. John Mancini, Scott Lear
  BMC Cardiovascular Disorders.2021;[Epub]     CrossRef
• Characterization of the hypertriglyceridemic waist phenotype in patients with type 2 diabetes mellitus in Spain: an epidemiological study
  I. Miñambres, J. Sánchez-Hernandez, G. Cuixart, A. Sánchez-Pinto, J. Sarroca, A. Pérez
  Revista Clínica Española (English Edition).2021; 221(10): 576.     CrossRef
• Association between Hypertriglyceridemic-Waist Phenotype and Risk of Type 2 Diabetes Mellitus in Middle-Aged and Older Chinese Population: A Longitudinal Cohort Study
  Dezhong Chen, Ziyun Liang, Huimin Sun, Ciyong Lu, Weiqing Chen, Harry H. X. Wang, Vivian Yawei Guo
  International Journal of Environmental Research and Public Health.2021; 18(18): 9618.     CrossRef
• Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Study in Chinese Women
  Yujuan Xiang, Wenzhong Zhou, Xuening Duan, Zhimin Fan, Shu Wang, Shuchen Liu, Liyuan Liu, Fei Wang, Lixiang Yu, Fei Zhou, Shuya Huang, Liang Li, Qiang Zhang, Qinye Fu, Zhongbing Ma, Dezong Gao, Shude Cui, Cuizhi Geng, Xuchen Cao, Zhenlin Yang, Xiang Wang,
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Hypertriglyceridemic Waist Phenotype and Lipid Accumulation Product: Two Comprehensive Obese Indicators of Waist Circumference and Triglyceride to Predict Type 2 Diabetes Mellitus in Chinese Population
  Minrui Xu, Mingtao Huang, Deren Qiang, Jianxin Gu, Yong Li, Yingzi Pan, Xingjuan Yao, Wenchao Xu, Yuan Tao, Yihong Zhou, Hongxia Ma, Ulrike Rothe
  Journal of Diabetes Research.2020; 2020: 1.     CrossRef
• Prevalence and relationship of hypertriglyceridaemic–waist phenotype and type 2 diabetes mellitus among a rural adult Chinese population
  Yong-Cheng Ren, Yu Liu, Xi-Zhuo Sun, Bing-Yuan Wang, Yi Liu, Hu Ni, Yang Zhao, Dechen Liu, Xuejiao Liu, Dongdong Zhang, Feiyan Liu, Cheng Cheng, Leilei Liu, Xu Chen, Qionggui Zhou, Ming Zhang, Dongsheng Hu
  Public Health Nutrition.2019; 22(8): 1361.     CrossRef
• Hypertriglyceridemic waist phenotype and abnormal glucose metabolism: a system review and meta-analysis
  Chun-Ming Ma, Xiao-Li Liu, Na Lu, Rui Wang, Qiang Lu, Fu-Zai Yin
  Endocrine.2019; 64(3): 469.     CrossRef
• Superior Role of Waist Circumference to Body-Mass Index in the Prediction of Cardiometabolic Risk in Dyslipidemic Patients
  Ľ. Cibičková, K. Langová, H. Vaverková, J. Lukeš, N. Cibiček
  Physiological Research.2019; : 931.     CrossRef
• Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
  Eun-Jung Rhee
  Diabetes & Metabolism Journal.2018; 42(1): 19.     CrossRef
• Letter: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017;32:221-9, Mohsen Janghorbani et al.)
  Eun-Jung Rhee
  Endocrinology and Metabolism.2017; 32(3): 396.     CrossRef
• The Relationship between Hypertriglyceridemic Waist Phenotype and Early Diabetic Nephropathy in Type 2 Diabetes
  Chun-Ming Ma, Rui Wang, Xiao-Li Liu, Na Lu, Qiang Lu, Fu-Zai Yin
  Cardiorenal Medicine.2017; 7(4): 295.     CrossRef
• The Association of Hypertriglyceridemic Waist Phenotype with Chronic Kidney Disease and Its Sex Difference: A Cross-Sectional Study in an Urban Chinese Elderly Population
  Jing Zeng, Miao Liu, Lei Wu, Jianhua Wang, Shanshan Yang, Yiyan Wang, Yao Yao, Bin Jiang, Yao He
  International Journal of Environmental Research and Public Health.2016; 13(12): 1233.     CrossRef
• Prevalence of hypertriglyceridemic waist and association with risk of type 2 diabetes mellitus: a meta‐analysis
  Yongcheng Ren, Xinping Luo, Chongjian Wang, Lei Yin, Chao Pang, Tianping Feng, Bingyuan Wang, Lu Zhang, Linlin Li, Xiangyu Yang, Hongyan Zhang, Jingzhi Zhao, Dongsheng Hu
  Diabetes/Metabolism Research and Reviews.2016; 32(4): 405.     CrossRef
• Utility of hypertriglyceridemic waist phenotype for predicting incident type 2 diabetes: The Isfahan Diabetes Prevention Study
  Mohsen Janghorbani, Masoud Amini
  Journal of Diabetes Investigation.2016; 7(6): 860.     CrossRef
• βig-h3 Represses T-Cell Activation in Type 1 Diabetes
  Maeva Patry, Romain Teinturier, Delphine Goehrig, Cornelia Zetu, Doriane Ripoche, In-San Kim, Philippe Bertolino, Ana Hennino
  Diabetes.2015; 64(12): 4212.     CrossRef
• Hypertriglyceridemic Waist – a Simple Clinical Tool to Detect Cardiometabolic Risk: Comparison With Harmonized Definition of Metabolic Syndrome
  H. VAVERKOVÁ, D. KARÁSEK, D. NOVOTNÝ, M. HALENKA, J. ORSÁG, L. SLAVÍK
  Physiological Research.2015; : S385.     CrossRef
• Articles in 'Endocrinology and Metabolism' in 2014
  Won-Young Lee
  Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
• Changes in Metabolic Health Status Over Time and Risk of Developing Type 2 Diabetes
  Seung-Hwan Lee, Hae Kyung Yang, Hee-Sung Ha, Jin-Hee Lee, Hyuk-Sang Kwon, Yong-Moon Park, Hyeon-Woo Yim, Moo-Il Kang, Won-Chul Lee, Ho-Young Son, Kun-Ho Yoon
  Medicine.2015; 94(40): e1705.     CrossRef

Citations

Citations to this article as recorded by  

• Acute Pancreatitis in a Pregnant Patient with Type IV Hyperlipoproteinemia
  Sang Ho Lee, Jae Hyuck Jun, Young Seok Doh, Ji Woong Jang, Sae Hee Kim, Il Hyun Baek, Sung Hee Jung
  The Korean Journal of Pancreas and Biliary Tract.2019; 24(2): 73.     CrossRef
• Hypertriglyceridemia-Induced Acute Pancreatitis
  Jin Myung Park
  The Korean Journal of Pancreas and Biliary Tract.2017; 22(4): 158.     CrossRef
• Cheese-like Material in the Heart: An Autopsy Case Report of Severe Hypertriglyceridemia in Diabetic Ketoacidosis Patient
  Joo Young Na, Eun Hee Kim, Bon Young Koo, Ik Jo Chung, Byung Ha Choi, Nak Eun Chung
  Korean Journal of Legal Medicine.2013; 37(4): 212.     CrossRef